STEPHANIE ZIMMERMAN: Open Payments
NPI 1396299061 · MARTINEZ, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,106 in 49 payments from 18 companies in 2025. Trend: 2023 $276 · 2024 $755 · 2025 $1,106
Food & beverage: $931Education: $175
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $246 |
| Janssen Biotech, Inc. | 6 | $240 |
| Regeneron Healthcare Solutions, Inc. | 3 | $96 |
| LEO Pharma Inc. | 4 | $85 |
| Amgen Inc. | 3 | $65 |
| Incyte Corporation | 2 | $46 |
| Organon LLC | 3 | $41 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 2 | $38 |
| Galderma Laboratories, L.P. | 2 | $35 |
| E.R. Squibb & Sons, L.L.C. | 2 | $34 |
Products named: TREMFYA, SKYRIZI, DUPIXENT, ADBRY, OTEZLA, Opzelura, RINVOQ, Cabtreo.
Industry payments across GA — which companies pay providers there.
